Suchergebnisse - "Azuma, Arata"

PubPharm (320)

1

Japanese guidelines for the treatment of idiopathic pulmonary fibrosis 2023:Revised edition

enthalten in: Respiratory investigation | 2024

von Bando, M. | Homma, S. | Date, H. | +15

2

Treatment of Systemic Sclerosis-associated Interstitial Lung Disease : Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline

enthalten in: American journal of respiratory and critical care medicine | 2024

von Raghu, G. | Montesi, S. | Silver, R. | +21

3

A prospective cohort study of periostin as a serum biomarker in patients with idiopathic pulmonary fibrosis treated with nintedanib

enthalten in: Scientific reports | 2023

von Okamoto, M. | Fujimoto, K. | Johkoh, T. | +35

4

A highly specific antibody against the core fucose of the N-glycan in IgG identifies the pulmonary diseases and its regulation by CCL2

enthalten in: The Journal of biological chemistry | 2023

von Kanto, N. | Ohkawa, Y. | Kitano, M. | +14

5

Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD)

enthalten in: BMJ open respiratory research | 2023

von Maher, T. | Assassi, S. | Azuma, A. | +12

6

Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF)

enthalten in: BMJ open respiratory research | 2023

von Richeldi, L. | Azuma, A. | Cottin, V. | +10

7

Exploratory phase 2 study of the novel oral multi-kinase inhibitor TAS-115 in patients with idiopathic pulmonary fibrosis

enthalten in: Respiratory investigation | 2023

von Nishioka, Y. | Homma, S. | Ogura, T. | +10

8

Core Fucosylation Is Required for the Secretion of and the Enzymatic Activity of SOD3 in Nonsmall-Cell Lung Cancer Cells

enthalten in: Antioxidants & redox signaling | 2023

von Ohkawa, Y. | Kitano, M. | Maeda, K. | +9

9

Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis : Interim Report of a Post-Marketing Surveillance in Japan

enthalten in: Advances in therapy | 2023

von Ogura, T. | Inoue, Y. | Azuma, A. | +6

10

A randomized controlled phase III trial protocol : perioperative pirfenidone therapy in patients with non-small cell lung cancer combined with idiopathic pulmonary fibrosis to confirm the preventative effect against postoperative acute exacerbation: the PIII-PEOPLE study (NEJ034)

enthalten in: Journal of thoracic disease | 2023

von Sakairi, Y. | Yoshino, I. | Iwata, T. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[32]